Earnings History Data for Intercept Pharmaceuticals, Inc. (ICPT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat chronic liver disease. The company's lead product candidate, obeticholic acid, or OCA, is a bile acid analog and first-in-class agonist of the farnesoid X receptor (FXR). OCA is initially being developed for the second line treatment of primary biliary cirrhosis (PBC). Intercept Pharmaceuticals Inc. is headquartered in New York.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
02-08-2023 PM ICPT Intercept Pharmaceuticals, Inc. 450.22 -0.14 -0.56 -0.68 Intercept Pharma beats Q2 top and bottom line estimates; updates FY23 outlook
[8/2/2023 7:06 AM]
10.94 0.44 
(4.19%)
11.40 0.90 
(8.57%)
8.82 - 21.86 1,402,627 660,000 8,790
27-04-2023 PM 7:00 AM ET
(Apr 27)
ICPT Intercept Pharmaceuticals, Inc. 765.90 -0.77 -0.57 -0.58 Intercept Pharma GAAP EPS of -$0.77 misses by $0.15, revenue of $68M misses by $4.68M
[4/27/2023 7:08 AM]
15.93 -2.41 
(-13.17%)
18.00 -0.34 
(-1.86%)
10.81 - 21.86 1,714,094 680,000 1,401
02-03-2023 PM 7:00 AM ET
(Mar 2)
ICPT Intercept Pharmaceuticals, Inc. 804.73 -0.42 -0.53 -1.23 Intercept Pharma GAAP EPS of -$0.50 misses by $0.26, revenue of $77.22M misses by $0.86M
[3/2/2023 7:05 AM]
20.71 0.90 
(4.54%)
19.75 -0.06 
(-0.30%)
10.81 - 21.86 736,564 720,000 756
01-11-2022 PM 7:00 AM ET
(Nov 1)
ICPT Intercept Pharmaceuticals, Inc. 589.36 -3.04 5.11 -0.63 Intercept PharmaEPS of -$3.04, revenue of $77.59M
[11/1/2022 7:09 AM]
15.74 1.88 
(13.52%)
14.34 0.47 
(3.39%)
10.81 - 21.25 1,499,910 630,000 289
03-08-2022 PM 7:00 AM ET
(Aug 3)
ICPT Intercept Pharmaceuticals, Inc. 417.47 -0.68 -0.53 -0.33 Intercept Pharma GAAP EPS of -$0.68, revenue of $71.76M
[8/3/2022 7:06 AM]
13.82 1.57 
(12.82%)
12.39 0.14 
(1.14%)
10.81 - 20.50 1,400,520 700,000 3,107
06-05-2022 PM 7:00 AM ET
(May 6)
ICPT Intercept Pharmaceuticals, Inc. 480.72 -0.58 -0.89 -1.22 Intercept Pharma GAAP EPS of -$0.58 beats by $0.37, revenue of $88.58M misses by $1.9M
[5/6/2022 7:03 AM]
19.27 -0.32 
(-1.63%)
19.27 0.0 
(0.00%)
11.60 - 22.36 2,390,644 1,960,000 11,072
02-03-2022 PM 7:00 AM ET
(Mar 2)
ICPT Intercept Pharmaceuticals, Inc. 421.34 -1.23 -1.25 -1.58 Intercept Pharma GAAP EPS of -$1.23 misses by $0.18, revenue of $92.4M beats by $0.31M
[3/2/2022 7:02 AM]
13.55 -1.45 
(-9.68%)
13.83 -1.17 
(-7.80%)
11.60 - 25.27 1,867,867 750,000 21,588
03-11-2021 PM 7:00 AM ET
(Nov 3)
ICPT Intercept Pharmaceuticals, Inc. 493.86 -0.63 1.00 -2.01 Intercept Pharma EPS beats by $0.98, beats on revenue
[11/3/2021 7:01 AM]
19.35 1.90 
(10.89%)
18.44 0.99 
(5.67%)
11.60 - 40.41 2,705,476 510,000 46,751
29-07-2021 PM 7:00 AM ET
(Jul 29)
ICPT Intercept Pharmaceuticals, Inc. 544.85 -0.33 -1.24 -1.92 Intercept Pharma EPS beats by $0.89, beats on revenue
[7/29/2021 7:06 AM]
17.37 0.50 
(2.96%)
18.10 1.23 
(7.29%)
13.88 - 55.59 604,495 500,000 15,638
06-05-2021 PM 7:00 AM ET
(May 6)
ICPT Intercept Pharmaceuticals, Inc. 635.39 -1.22 -1.53 -2.86 Intercept Pharma EPS beats by $0.27, beats on revenue; narrows guidance
[5/6/2021 7:06 AM]
17.01 -2.03 
(-10.66%)
17.01 0.0 
(0.00%)
16.81 - 95.98 1,831,775 880,000 19,653
25-02-2021 PM 7:00 AM ET
(Feb 25)
ICPT Intercept Pharmaceuticals, Inc. 927.75 -1.58 -1.55 -2.99 Intercept Pharma EPS misses by $0.09, misses on revenue
[2/25/2021 7:05 AM]
23.02 -0.20 
(-19.51%)
28.40 -0.20 
(-0.70%)
23.01 - 98.03 2,185,220 785,468 2,623
09-11-2020 PM 7:00 AM ET
(Nov 9)
ICPT Intercept Pharmaceuticals, Inc. 970.30 -2.01 -1.96 -2.59 Intercept Pharma EPS misses by $0.04, beats on revenue
[11/9/2020 7:01 AM]
34.84 6.69 
(23.77%)
29.50 1.35 
(4.80%)
27.02 - 125.00 2,872,851 633,468 11,345
10-08-2020 PM 7:00 AM ET
(Aug 10)
ICPT Intercept Pharmaceuticals, Inc. 1,550 -1.92 -2.88 -2.28 Intercept Pharma EPS beats by $1.01, beats on revenue
[8/10/2020 7:05 AM]
50.96 2.22 
(4.54%)
50.00 1.25 
(2.56%)
42.19 - 125.00 1,371,965 652,264 11,759